vs
AFFILIATED MANAGERS GROUP, INC.（AMG）与Astrana Health, Inc.（ASTH）财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是AFFILIATED MANAGERS GROUP, INC.的1.7倍（$950.5M vs $556.6M），AFFILIATED MANAGERS GROUP, INC.净利率更高（62.4% vs 0.7%，领先61.7%），Astrana Health, Inc.同比增速更快（42.9% vs 6.2%），AFFILIATED MANAGERS GROUP, INC.自由现金流更多（$254.5M vs $-6.0M），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs 5.5%）
Affiliated Managers Group（简称AMG）是一家成立于1993年的美国金融服务企业，总部位于佛罗里达州西棕榈滩。公司股票在纽约证券交易所挂牌交易，代码为AMG，同时是标普400美国中型企业指数的成份股。
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
AMG vs ASTH — 直观对比
营收规模更大
ASTH
是对方的1.7倍
$556.6M
营收增速更快
ASTH
高出36.7%
6.2%
净利率更高
AMG
高出61.7%
0.7%
自由现金流更多
AMG
多$260.4M
$-6.0M
两年增速更快
ASTH
近两年复合增速
5.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $556.6M | $950.5M |
| 净利润 | $347.5M | $6.6M |
| 毛利率 | — | — |
| 营业利润率 | 94.4% | 1.9% |
| 净利率 | 62.4% | 0.7% |
| 营收同比 | 6.2% | 42.9% |
| 净利润同比 | 114.2% | 184.4% |
| 每股收益（稀释后） | $10.87 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMGASTH
| Q4 25 | $556.6M | $950.5M | ||
| Q3 25 | $528.0M | $956.0M | ||
| Q2 25 | $493.2M | $654.8M | ||
| Q1 25 | $496.6M | $620.4M | ||
| Q4 24 | $524.3M | $665.2M | ||
| Q3 24 | $516.4M | $478.7M | ||
| Q2 24 | $500.3M | $486.3M | ||
| Q1 24 | $499.9M | $404.4M |
净利润AMGASTH
| Q4 25 | $347.5M | $6.6M | ||
| Q3 25 | $212.4M | $373.0K | ||
| Q2 25 | $84.3M | $9.4M | ||
| Q1 25 | $72.4M | $6.7M | ||
| Q4 24 | $162.2M | $-7.8M | ||
| Q3 24 | $123.6M | $16.1M | ||
| Q2 24 | $76.0M | $19.2M | ||
| Q1 24 | $149.8M | $14.8M |
营业利润率AMGASTH
| Q4 25 | 94.4% | 1.9% | ||
| Q3 25 | 68.7% | 2.0% | ||
| Q2 25 | 34.8% | 3.1% | ||
| Q1 25 | 25.5% | 3.3% | ||
| Q4 24 | 52.2% | 0.1% | ||
| Q3 24 | 42.0% | 5.9% | ||
| Q2 24 | 35.6% | 6.2% | ||
| Q1 24 | 50.8% | 7.5% |
净利率AMGASTH
| Q4 25 | 62.4% | 0.7% | ||
| Q3 25 | 40.2% | 0.0% | ||
| Q2 25 | 17.1% | 1.4% | ||
| Q1 25 | 14.6% | 1.1% | ||
| Q4 24 | 30.9% | -1.2% | ||
| Q3 24 | 23.9% | 3.4% | ||
| Q2 24 | 15.2% | 3.9% | ||
| Q1 24 | 30.0% | 3.7% |
每股收益（稀释后）AMGASTH
| Q4 25 | $10.87 | $0.12 | ||
| Q3 25 | $6.87 | $0.01 | ||
| Q2 25 | $2.80 | $0.19 | ||
| Q1 25 | $2.20 | $0.14 | ||
| Q4 24 | $4.95 | $-0.14 | ||
| Q3 24 | $3.78 | $0.33 | ||
| Q2 24 | $2.26 | $0.40 | ||
| Q1 24 | $4.14 | $0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $586.0M | $429.5M |
| 总债务越低越好 | $2.7B | — |
| 股东权益账面价值 | $3.2B | $779.3M |
| 总资产 | $9.2B | $2.2B |
| 负债/权益比越低杠杆越低 | 0.83× | — |
8季度趋势，按日历期对齐
现金及短期投资AMGASTH
| Q4 25 | $586.0M | $429.5M | ||
| Q3 25 | $476.1M | $463.4M | ||
| Q2 25 | $361.0M | $342.1M | ||
| Q1 25 | $816.5M | $260.9M | ||
| Q4 24 | $950.0M | $290.8M | ||
| Q3 24 | $1.0B | $350.3M | ||
| Q2 24 | $865.5M | $327.7M | ||
| Q1 24 | $793.4M | $337.3M |
总债务AMGASTH
| Q4 25 | $2.7B | — | ||
| Q3 25 | $2.4B | — | ||
| Q2 25 | $2.6B | — | ||
| Q1 25 | $2.6B | — | ||
| Q4 24 | $2.6B | — | ||
| Q3 24 | $2.6B | — | ||
| Q2 24 | $2.5B | — | ||
| Q1 24 | $2.5B | — |
股东权益AMGASTH
| Q4 25 | $3.2B | $779.3M | ||
| Q3 25 | $3.3B | $775.5M | ||
| Q2 25 | $3.2B | $765.5M | ||
| Q1 25 | $3.2B | $745.4M | ||
| Q4 24 | $3.3B | $712.7M | ||
| Q3 24 | $3.3B | $704.6M | ||
| Q2 24 | $3.3B | $678.9M | ||
| Q1 24 | $3.6B | $653.5M |
总资产AMGASTH
| Q4 25 | $9.2B | $2.2B | ||
| Q3 25 | $8.9B | $2.2B | ||
| Q2 25 | $8.8B | $1.4B | ||
| Q1 25 | $8.7B | $1.3B | ||
| Q4 24 | $8.8B | $1.4B | ||
| Q3 24 | $8.9B | $1.3B | ||
| Q2 24 | $8.8B | $1.3B | ||
| Q1 24 | $9.0B | $1.2B |
负债/权益比AMGASTH
| Q4 25 | 0.83× | — | ||
| Q3 25 | 0.71× | — | ||
| Q2 25 | 0.81× | — | ||
| Q1 25 | 0.82× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | 0.79× | — | ||
| Q2 24 | 0.76× | — | ||
| Q1 24 | 0.70× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $256.4M | $-2.9M |
| 自由现金流经营现金流 - 资本支出 | $254.5M | $-6.0M |
| 自由现金流率自由现金流/营收 | 45.7% | -0.6% |
| 资本支出强度资本支出/营收 | 0.3% | 0.3% |
| 现金转化率经营现金流/净利润 | 0.74× | -0.44× |
| 过去12个月自由现金流最近4个季度 | $967.1M | $104.5M |
8季度趋势，按日历期对齐
经营现金流AMGASTH
| Q4 25 | $256.4M | $-2.9M | ||
| Q3 25 | $277.1M | $10.0M | ||
| Q2 25 | $230.8M | $90.9M | ||
| Q1 25 | $208.9M | $16.6M | ||
| Q4 24 | $212.5M | $-10.9M | ||
| Q3 24 | $265.2M | $34.0M | ||
| Q2 24 | $245.2M | $23.2M | ||
| Q1 24 | $209.2M | $6.0M |
自由现金流AMGASTH
| Q4 25 | $254.5M | $-6.0M | ||
| Q3 25 | $275.9M | $7.4M | ||
| Q2 25 | $229.4M | $89.5M | ||
| Q1 25 | $207.3M | $13.6M | ||
| Q4 24 | $211.4M | $-13.5M | ||
| Q3 24 | $264.5M | $31.7M | ||
| Q2 24 | $244.6M | $20.4M | ||
| Q1 24 | $208.2M | $5.6M |
自由现金流率AMGASTH
| Q4 25 | 45.7% | -0.6% | ||
| Q3 25 | 52.3% | 0.8% | ||
| Q2 25 | 46.5% | 13.7% | ||
| Q1 25 | 41.7% | 2.2% | ||
| Q4 24 | 40.3% | -2.0% | ||
| Q3 24 | 51.2% | 6.6% | ||
| Q2 24 | 48.9% | 4.2% | ||
| Q1 24 | 41.6% | 1.4% |
资本支出强度AMGASTH
| Q4 25 | 0.3% | 0.3% | ||
| Q3 25 | 0.2% | 0.3% | ||
| Q2 25 | 0.3% | 0.2% | ||
| Q1 25 | 0.3% | 0.5% | ||
| Q4 24 | 0.2% | 0.4% | ||
| Q3 24 | 0.1% | 0.5% | ||
| Q2 24 | 0.1% | 0.6% | ||
| Q1 24 | 0.2% | 0.1% |
现金转化率AMGASTH
| Q4 25 | 0.74× | -0.44× | ||
| Q3 25 | 1.30× | 26.69× | ||
| Q2 25 | 2.74× | 9.65× | ||
| Q1 25 | 2.89× | 2.48× | ||
| Q4 24 | 1.31× | — | ||
| Q3 24 | 2.15× | 2.11× | ||
| Q2 24 | 3.23× | 1.21× | ||
| Q1 24 | 1.40× | 0.40× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMG
暂无分部数据
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
